URGN
UroGen Pharma Ltd.
$17.99
+$0.04(+0.22%)
75
Overall
--
Value
75
Tech
--
Quality
Market Cap
$835.99M
Volume
1.16M
52W Range
$3.42 - $21.71
Target Price
$35.22
Key Metrics Overview
| Market Cap | $835.99M | P/E Ratio | N/A |
| 52W High | $21.71 | 52W Low | $3.42 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 15.8% | 52W Position | 79.7% |
| Overall Score | 75 | Value Score | -- |
| Quality Score | -- | Technical Score | 75 |
Growth Analysis
| EPS Current Est | $-3.06 | EPS Next Est | $-1.09 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | URGN | $17.99 | +0.2% | 1.16M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |